Targeted Drugs for Patients With ROS1 Rearrangement With NSCLC: General Approach, Side Effects, New Drugs in the Pipeline

PrecisCa

PrecisCa supports patients, their caregivers, and health care providers at every step of their cancer journeys from diagnosis to remission, with up-to-date education on the latest advancements in cancer care and access to leading specialists to analyze patient scenarios

https://precisca.com/